Extracorporeal membrane oxygenation (ECMO) for respiratory support in adults
NHS Quality Improvement Scotland (NHS QIS)
Record ID 32011000038
English
Authors' recommendations:
In a randomised controlled trial (CESAR) conducted by the UK national ECMO centre, referral for consideration of ECMO was associated with a statistically significant reduction in the risk of death or severe disability at 6 months compared with conventional management in a tertiary ICU.There are few published data on long-term outcomes following ECMO for respiratory failure in adults.The additional average health care cost per patient referred for ECMO in the CESAR trial was more than double the average cost of conventional management. The estimated costper additional QALY was £1,631,124.Robust cost effectiveness models need to be constructed locally.Due to its complexity and potential complications ECMO should only be provided in specialist centres.
Details
Project Status:
Completed
URL for project:
http://www.nhshealthquality.org/nhsqis/files/EN30_EMO.pdf
Year Published:
2010
URL for published report:
http://www.nhshealthquality.org/nhsqis/controller?p_service=Content.show&p_applic=CCC&pContentID=8017
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Scotland
MeSH Terms
- Adult
- Respiratory Insufficiency
Contact
Organisation Name:
Quality Improvement Scotland
Contact Address:
Delta House, 50 West Nile Street Glasgow G1 2NP Scotland United Kingdom Tel: +44 141 225 6988; Fax: +44 141 221 3262
Contact Name:
shtg.hcis@nhs.net
Contact Email:
shtg.hcis@nhs.net
Copyright:
NHS Quality Improvement Scotland (NHS QIS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.